Results 111 to 120 of about 76,308 (258)

Advanced Lung Cancer Inflammation Index as a Prognostic Inflammation–Nutrition Marker in Appendiceal High‐Grade Pseudomyxoma Peritonei: A 10‐Year Single‐Center Study

open access: yesANZ Journal of Surgery, EarlyView.
Among 223 patients with appendiceal high‐grade pseudomyxoma peritonei, a high advanced lung cancer inflammation index (ALI) was independently associated with improved overall survival. A nomogram integrating ALI with clinicopathological and surgical factors showed good discrimination, calibration, and clinical utility for predicting 1‐, 2‐, and 3‐year ...
Yun Gao   +4 more
wiley   +1 more source

Clinical Outcomes After Percutaneous Coronary Intervention in Patients With Cirrhosis: A Multicentre National Study

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
Summary of a multicentre TriNetX study evaluating outcomes after percutaneous coronary intervention (PCI) in patients with cirrhosis. Cirrhosis was associated with higher 1‐year gastrointestinal bleeding and mortality, especially with decompensated disease.
Dhir Gala   +13 more
wiley   +1 more source

How and when do peer deviant behaviours link to adolescent academic performance?: Longitudinal moderated mediation analysis using a Chinese national sample

open access: yesBritish Journal of Educational Psychology, EarlyView.
Abstract Background Previous research has associated peer deviant behaviours with lower academic performance in adolescents. However, the mediation and moderation mechanisms underlying this relationship, particularly the moderating role of educational expectations, require further exploration.
Yu Sun, Kaiji Zhou, Jacky C. K. Ng
wiley   +1 more source

Effectiveness of Glucocorticoids in the No-Reflow Phenomenon in STEMI Patients

open access: yesУкраїнський журнал серцево-судинної хірургії
Relevance. The driving force behind the pathogenesis of no-reflow, as a component of ischemic-reperfusion injury, is myocardial edema, which provokes extravascular compression of the infarct-related artery (IRA), making it impossible to restore antegrade
Maksim Y. Sokolov   +3 more
doaj  

Intracoronary Vasoactive Therapy for No-Reflow During Primary PCI: A Network Meta-Analysis of Randomized Trials. [PDF]

open access: yesJACC Adv
Oliveri F   +9 more
europepmc   +1 more source

Zeb2 Controls Retinal Physiological and Pathological Angiogenesis by Regulating Astrocyte Proliferation and Differentiation

open access: yesCell Proliferation, EarlyView.
During development, the oxygen‐sensitive transcription factor Zeb2 restrains astrocyte proliferation and maturation to ensure balanced retinal angiogenesis. In disease, it promotes the neurotoxic A1 astrocyte phenotype and inflammation, thereby promoting reparative revascularization over pathological neovascularization.
Jing Liu   +5 more
wiley   +1 more source

Intracoronary ECG May Reveal Dynamic Changes in Tissue-Level Reperfusion During Primary PCI. [PDF]

open access: yesJACC Case Rep
Aslanger EK   +7 more
europepmc   +1 more source

Role of Sodium Nitroprusside in Primary PCI

open access: yesOpen Access Journal of Cardiology
Sodium nitroprusside (SNP), a potent vasodilator with a rapid onset and short duration of action, has traditionally been used to manage acute hypertension in emergency settings. Its mechanism of action involves the release of nitric oxide (NO), leading to vascular smooth muscle relaxation.
openaire   +1 more source

Clinical characteristics and in‐hospital mortality among insulin pump users with acute coronary syndrome in the predominantly open‐loop era: A UK‐wide MINAP registry analysis

open access: yesDiabetic Medicine, EarlyView.
Abstract Background We compared characteristics of adults with insulin‐treated diabetes using continuous subcutaneous insulin infusion (CSII) versus multiple daily insulin injections (MDI) during admission with acute coronary syndrome (ACS) and identified factors associated with in‐hospital mortality among CSII users.
Harshal Deshmukh   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy